跳至主要内容
临床试验/NCT03195257
NCT03195257已完成不适用

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

Mikkel Christensen0 个研究点目标入组 10 人开始时间: 2012年11月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
主要终点
C-terminal telopeptide of type I collagen (CTX).

研究概览

简要总结

Investigate GIP effects on biomarkers involved in bone homeostasis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Randomized, double-blinded, cross-over study with 5 study days.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients with type 1 diabetes (positive islet cell/ glutamic acid decarboxylase-65 antibodies)
  • Patients without measurable beta cell function (i.e. incremental C-peptide below detection limit (<0.16 nmol/l) following an 5 g-iv-arginine stimulation test,

排除标准

  • HbA1c >9% (75 mmol/mol),
  • standard plasma biochemical measurements outside normal reference interval (alanine aminotransferase, bilirubin, thyroid-stimulating hormone, hemoglobin, creatinine, and spot urine albumin-creatinine ratio);
  • an abnormal state of hypoglycemia awareness,
  • significant diabetic complications (i.e. proliferative diabetic retinopathy, neuropathy, severe atherosclerosis, heart disease) and,
  • treatment with medication (besides insulin) that could not be paused for 12 hours up to and during the days of the experiments.

研究组 & 干预措施

Hypoglycemia-GLP-1

Active Comparator

干预措施: GLP-1 (Other)

结局指标

主要结局

C-terminal telopeptide of type I collagen (CTX).

时间窗: 30 minutes intervals, time 0 up to 120 min

次要结局

  • N-terminal propeptide of type 1 procollagen (P1NP).(30 minutes intervals, time 0 up to 120 min)
  • Parathyroid hormone (PTH)(30 minutes intervals, time 0 up to 120 min)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mikkel Christensen

Associate Professor, Principal Investigator

University Hospital, Gentofte, Copenhagen

相似试验